HUTCHMED (China) Limited
HCM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,465 | $3,077 | $2,504 | $5,561 |
| - Cash | $154 | $284 | $313 | $378 |
| + Debt | $90 | $86 | $27 | $39 |
| Enterprise Value | $2,401 | $2,880 | $2,218 | $5,223 |
| Revenue | $630 | $838 | $426 | $356 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Gross Profit | $281 | $454 | $115 | $98 |
| % Margin | 44.6% | 54.1% | 27% | 27.5% |
| EBITDA | $14 | $67 | -$401 | -$208 |
| % Margin | 2.2% | 8% | -94.1% | -58.4% |
| Net Income | $38 | $101 | -$361 | -$195 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS Diluted | 0.22 | 0.6 | -2.15 | -1.25 |
| % Growth | -63.3% | 127.9% | -72% | – |
| Operating Cash Flow | $0 | $219 | -$269 | -$204 |
| Capital Expenditures | -$18 | -$33 | -$37 | -$17 |
| Free Cash Flow | -$17 | $187 | -$305 | -$221 |